收费全文 | 159495篇 |
免费 | 8624篇 |
国内免费 | 762篇 |
耳鼻咽喉 | 1751篇 |
儿科学 | 5391篇 |
妇产科学 | 3455篇 |
基础医学 | 22464篇 |
口腔科学 | 5231篇 |
临床医学 | 13365篇 |
内科学 | 36667篇 |
皮肤病学 | 4394篇 |
神经病学 | 14798篇 |
特种医学 | 3655篇 |
外国民族医学 | 1篇 |
外科学 | 16229篇 |
综合类 | 686篇 |
一般理论 | 73篇 |
预防医学 | 15581篇 |
眼科学 | 3153篇 |
药学 | 10706篇 |
中国医学 | 663篇 |
肿瘤学 | 10618篇 |
2024年 | 166篇 |
2023年 | 1382篇 |
2022年 | 2722篇 |
2021年 | 5093篇 |
2020年 | 2967篇 |
2019年 | 4565篇 |
2018年 | 5688篇 |
2017年 | 3958篇 |
2016年 | 4222篇 |
2015年 | 4523篇 |
2014年 | 5945篇 |
2013年 | 8203篇 |
2012年 | 12805篇 |
2011年 | 13640篇 |
2010年 | 7249篇 |
2009年 | 5719篇 |
2008年 | 10796篇 |
2007年 | 10884篇 |
2006年 | 10021篇 |
2005年 | 9642篇 |
2004年 | 8678篇 |
2003年 | 7992篇 |
2002年 | 7177篇 |
2001年 | 2097篇 |
2000年 | 2373篇 |
1999年 | 1678篇 |
1998年 | 1151篇 |
1997年 | 892篇 |
1996年 | 756篇 |
1995年 | 642篇 |
1994年 | 602篇 |
1993年 | 494篇 |
1992年 | 437篇 |
1991年 | 315篇 |
1990年 | 295篇 |
1989年 | 271篇 |
1988年 | 266篇 |
1987年 | 208篇 |
1986年 | 217篇 |
1985年 | 182篇 |
1984年 | 212篇 |
1983年 | 190篇 |
1982年 | 204篇 |
1981年 | 155篇 |
1980年 | 168篇 |
1979年 | 103篇 |
1978年 | 118篇 |
1977年 | 105篇 |
1976年 | 85篇 |
1975年 | 74篇 |
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
![点击此处可从《Acta paediatrica (Oslo, Norway : 1992)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Methods: A total of 32 HIV+ patients, 11 with uveitis/retinitis before surgery and 21 without, mean follow-up 44.9 ± 36.6 months, and 114 HIV- patients, 57 with uveitis/retinitis before surgery and 57 without, were retrospectively compared.
Results: Visual acuity improved in all HIV+ patients (p < 0.001), who were younger (p = 0.01) and more frequently males (p = 0.027). HIV+ patients with uveitis prior surgery improved less (p = 0.046) than HIV- (p < 0.001); their anterior chamber inflammation was similar to baseline. Male sex (p = 0.005), younger age (p < 0.001), dyslipidaemia (p = 0.058), HBV+ (p = 0.037), and unilateral cataract (p = 0.001) were more frequent in HIV+ patients with senile cataract, but they showed the same postoperative course as HIV- patients.
Conclusion: Cataract surgery in HIV+ patients is safe and effective. Uveitis prior to surgery did not significantly affect the postoperative course. Systemic comorbidities are more frequent in HIV+ patients with senile cataract than in HIV- subjects. 相似文献